S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Closing prices for crude oil, gold and other commodities
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Closing prices for crude oil, gold and other commodities
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Closing prices for crude oil, gold and other commodities
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
In his annual letter, Warren Buffett tells investors to ignore Wall Street pundits
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
Sprouts, Block rise; Booking Holdings, Insulet fall, Friday, 2/23/2024
How major US stock indexes fared Friday, 2/23/2024
SHOCKING Crypto Leak Reveal Crypto's Set To SURGE (Ad)
MarketBeat Week in Review – 2/19 - 2/23
Closing prices for crude oil, gold and other commodities
Claim Your FREE Ultimate Dividend Package (Seriously, put your wallet away!) (Ad)
Mark Zuckerberg Is Sitting on a Huge Stockpile of AI Chips as Companies Compete for Limited Supplies
Taiwan giant chipmaker TSMC opens first plant in Japan as part of key global expansion

Fortress Biotech (FBIO) News Today

$1.74
-0.01 (-0.57%)
(As of 02/23/2024 ET)
SourceHeadline
finance.yahoo.com logoCheckpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market
finance.yahoo.com - January 29 at 8:44 AM
finance.yahoo.com logoAvenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference
finance.yahoo.com - January 11 at 8:22 AM
finance.yahoo.com logoInsider Buying: President, CEO & Chairman, 10% Owner ROSENWALD LINDSAY A MD Acquires 50,000 ...
finance.yahoo.com - January 9 at 6:05 PM
finance.yahoo.com logoJourney Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea
finance.yahoo.com - January 5 at 9:26 AM
finance.yahoo.com logoAvenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds
finance.yahoo.com - January 5 at 9:26 AM
finance.yahoo.com logoAvenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV Tramadol
finance.yahoo.com - January 4 at 9:10 AM
finance.yahoo.com logoAvenue Therapeutics Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
finance.yahoo.com - January 2 at 9:00 AM
markets.businessinsider.com logoWhy Fortress Biotech Shares Are Tumbling Today
markets.businessinsider.com - December 29 at 11:50 AM
finance.yahoo.com logoMustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual Meeting
finance.yahoo.com - December 11 at 9:22 AM
finance.yahoo.com logoJourney Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea
finance.yahoo.com - December 6 at 9:07 AM
finance.yahoo.com logoSentynl Therapeutics Completes Asset Transfer of CUTX-101 Copper Histidinate Product Candidate for Treatment of Menkes Disease from Cyprium Therapeutics
finance.yahoo.com - December 6 at 9:07 AM
finance.yahoo.com logoCyprium Therapeutics, a Fortress Biotech Subsidiary Company, Completes Asset Transfer of CUTX-101 Copper Histidinate Product Candidate for Treatment of Menkes Disease, to Sentynl Therapeutics, a Wholly-owned Subsidiary of Zydus Lifesciences Ltd.
finance.yahoo.com - December 6 at 9:07 AM
benzinga.com logoFortress Biotech Stock (NASDAQ:FBIO), Analyst Ratings, Price Targets, Predictions
benzinga.com - December 1 at 3:00 PM
finance.yahoo.com logoAvenue Therapeutics to Present at American Epilepsy Society 2023 Annual Meeting
finance.yahoo.com - December 1 at 9:59 AM
markets.businessinsider.com logoRoth MKM Maintains Buy Rating for Fortress Biotech: Here's What You Need To Know
markets.businessinsider.com - November 29 at 2:13 PM
benzinga.com logoThinking about buying stock in Coinbase Global, Celsius Holdings, Cadence Design Systems, Coherus Biosciences, or Fortress Biotech?
benzinga.com - November 17 at 9:57 AM
finance.yahoo.com logoCheckpoint Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
finance.yahoo.com - November 13 at 7:31 PM
marketwatch.com logoFortress Biotech Shares Fall Premarket on Public Offering Plans
marketwatch.com - November 10 at 8:13 AM
finance.yahoo.com logoMustang Bio Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
finance.yahoo.com - October 26 at 1:34 PM
finance.yahoo.com logoJourney Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) vs. Solodyn® (Minocycline Hydrochloride Extended-Release Tablets, 105 mg)
finance.yahoo.com - October 20 at 9:04 AM
finance.yahoo.com logoCheckpoint Therapeutics Announces Publication of Cosibelimab Pivotal Trial Results in the Journal for ImmunoTherapy of Cancer
finance.yahoo.com - October 18 at 8:52 AM
finance.yahoo.com logoFortress Biotech Subsidiary Helocyte Announces Option Agreement with City of Hope for Exclusive Worldwide Rights to use a Novel Bispecific CMV/HIV CAR T Cell Therapy (optionally in combination with Triplex) for the Treatment of Adults Living with HIV-1
finance.yahoo.com - October 16 at 9:41 AM
wsj.com logoFortress Biotech Inc. 9.375% Cum. Pfd. Series A
wsj.com - September 22 at 6:25 PM
seekingalpha.com logoFortress Biotech, Inc. 9.375% CUM RED PER PREF SER A USD25.00 goes ex-dividend tomorrow
seekingalpha.com - September 13 at 3:50 PM
finance.yahoo.com logoMustang Bio to Participate in Upcoming September 2023 Investor Conferences
finance.yahoo.com - September 7 at 8:46 AM
finance.yahoo.com logoFortress Biotech to Present at H.C. Wainwright 25th Annual Global Investment Conference
finance.yahoo.com - September 7 at 8:46 AM
finance.yahoo.com logoJourney Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza® in South Korea and Other Asian Nations
finance.yahoo.com - September 6 at 8:51 AM
finance.yahoo.com logoMustang Bio Announces First Data from Ongoing Multicenter Phase 1/2 Clinical Trial Evaluating MB-106 CAR-T Cell Therapy
finance.yahoo.com - August 16 at 10:12 AM
finanznachrichten.de logoFortress Biotech, Inc.: Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
finanznachrichten.de - August 15 at 7:23 AM
finance.yahoo.com logoFortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
finance.yahoo.com - August 14 at 4:21 PM
finance.yahoo.com logoMustang Bio Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
finance.yahoo.com - August 14 at 4:21 PM
finance.yahoo.com logoJourney Medical Corporation Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
finance.yahoo.com - August 8 at 4:09 PM
finance.yahoo.com logoMustang Bio to Participate in Two August 2023 Investor Conferences
finance.yahoo.com - August 3 at 8:33 AM
finance.yahoo.com logoAvenue Therapeutics Announces High Potency and Full Efficacy in a Model of Generalized Seizures for its Novel GABA-A Receptor Potentiator, BAER-101, Supporting Phase 2 Clinical Study
finance.yahoo.com - August 1 at 3:32 PM
finance.yahoo.com logoInsiders Re-Evaluate Their US$3.4m Stock Purchase As Fortress Biotech Falls To US$77m
finance.yahoo.com - August 1 at 3:32 PM
finance.yahoo.com logoAvenue Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)
finance.yahoo.com - July 27 at 9:18 AM
finance.yahoo.com logoJourney Medical Corporation Expects Topline Results from the Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) for the Treatment of Papulopustular Rosacea to be Announced Week of July 10, 2023
finance.yahoo.com - July 3 at 9:12 AM
finance.yahoo.com logoUrica Therapeutics Announces Topline Data from the Phase 1 Clinical Trial Evaluating Dotinurad in Healthy Volunteers in the United States
finance.yahoo.com - June 29 at 9:08 AM
finance.yahoo.com logoCheckpoint Therapeutics Announces Presentation of New Cosibelimab Pharmacokinetic Data Supporting Extended-Interval Dosing
finance.yahoo.com - June 28 at 8:59 AM
finance.yahoo.com logoJourney Medical Corporation Announces Positive Topline Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adult Subjects
finance.yahoo.com - June 13 at 9:26 AM
finance.yahoo.com logoFortress Biotech, Inc. (NASDAQ:FBIO) Looks Inexpensive But Perhaps Not Attractive Enough
finance.yahoo.com - June 8 at 2:26 PM
msn.com logoFortress Biotech's Earnings: A Preview
msn.com - May 25 at 4:58 PM
finance.yahoo.com logoJourney Medical Corporation Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
finance.yahoo.com - May 22 at 6:15 PM
finance.yahoo.com logoJourney Medical Corporation to Announce First Quarter 2023 Financial Results on May 22, 2023
finance.yahoo.com - May 19 at 4:47 PM
msn.com logoCantor Fitzgerald Maintains Fortress Biotech (FBIO) Overweight Recommendation
msn.com - May 16 at 9:14 PM
msn.com logoFortress Biotech Non-GAAP EPS of -$0.06, revenue of $12.43M
msn.com - May 15 at 7:38 PM
finance.yahoo.com logoFortress Biotech (FBIO) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 15 at 7:38 PM
finance.yahoo.com logoJourney Medical Corporation Announces Postponement of First Quarter Financial Results Release and Conference Call
finance.yahoo.com - May 11 at 4:15 PM
finance.yahoo.com logoMustang Bio Announces Upcoming Presentations of Clinical Data from Phase 1/2 Trial of MB-106, a CD20-Targeted Autologous CAR T Cell Therapy
finance.yahoo.com - May 11 at 4:15 PM
finance.yahoo.com logoEarnings Preview: Fortress Biotech (FBIO) Q1 Earnings Expected to Decline
finance.yahoo.com - May 4 at 2:24 PM
Get Fortress Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for FBIO and its competitors with MarketBeat's FREE daily newsletter.



FBIO Media Mentions By Week

FBIO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

FBIO
News Sentiment

0.00

0.44

Average
Medical
News Sentiment

FBIO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

FBIO Articles
This Week

0

1

FBIO Articles
Average Week

Get Fortress Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for FBIO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:FBIO) was last updated on 2/24/2024 by MarketBeat.com Staff